title: DNase I primary transcript is alternatively spliced in both normal and apoptotic cells: no evidence of up-regulation in apoptosis.
abstract: The reverse transcriptase polymerase chain reaction (RT-PCR) was used to elucidate the expression of DNase I and its possible involvement in apoptotic genome degradation. Multiple PCR products were obtained from cDNAs of different rat and human cells. The subsequent cloning and sequence analysis of seven PCR products revealed that only one of them had the expected size (639 bp) and sequence identity to that of rat DNase I cDNA. The other six PCR products were characterized by either sequence insertions or deletions. To establish the origin of this molecular diversity, a genomic fragment of the rat DNase I gene was also isolated, subcloned, and sequenced. Sequence comparison of six cDNAs with the rat genomic DNA revealed that they, indeed, resulted from inclusion of introns or deletion of exons. Southern hybridizations of the RT-PCR products from a variety of mammalian cell lines, using the major DNase I cDNA fragment as a probe, showed that in some cells as many as 20 alternatively spliced transcripts could be detected. This complexity of splice variants was widespread, and cell-specific profiles differed by the relative concentration of each transcript. None of these spliced transcripts maintained an open reading frame containing an intact catalytic site, suggesting that they do not encode any functional proteins. These complicated alternative splicing events might, however, significantly contribute to the regulation of DNase I expression. There was no apparent increase of the major DNase I transcript after induction of apoptosis in the cell lines studied. Apoptotic cells appeared to have similar normal/alternative transcript ratios as the control cells, suggesting that DNase I may not be the endonuclease involved in DNA degradation during apoptosis.
authors.affiliation: Apoptosis Research Group, Institute for Biological Sciences, National Research Council of Canada, Ottawa, Ontario.
authors.forename: Q Y
authors.initials: QY
authors.lastname: Liu
authors.forename: M
authors.initials: M
authors.lastname: Ribecco
authors.forename: Y
authors.initials: Y
authors.lastname: Hou
authors.forename: P R
authors.initials: PR
authors.lastname: Walker
authors.forename: M
authors.initials: M
authors.lastname: Sikorska
mesh_terms: D016475:3T3 Cells; D000230:Adenocarcinoma; D017398:Alternative Splicing; D000818:Animals; D017209:Apoptosis / Q000502:physiology*; D001943:Breast Neoplasms; D002460:Cell Line; D003850:Deoxyribonuclease I / Q000096:biosynthesis*; D005047:Etoposide / Q000633:toxicity; D005091:Exons; D005260:Female; D015971:Gene Expression Regulation, Enzymologic; D015972:Gene Expression Regulation, Neoplastic / Q000187:drug effects; D006801:Humans; D019169:Jurkat Cells; D008114:Liver Neoplasms, Experimental; D008297:Male; D051379:Mice; D016716:PC12 Cells; D016133:Polymerase Chain Reaction; D011471:Prostatic Neoplasms; D051381:Rats; D014158:Transcription, Genetic; D014407:Tumor Cells, Cultured; D015854:Up-Regulation
chemical_list: D005047:Etoposide; D003850:Deoxyribonuclease I